Actively Recruiting

All Genders
NCT05978557

Brain Slice Explants to Predict Drug Response in Brain Tumors

Led by UNC Lineberger Comprehensive Cancer Center · Updated on 2025-08-29

50

Participants Needed

1

Research Sites

239 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This biospecimen collection study will evaluate the feasibility of engrafting and testing resected Central nervous system (CNS) tumors tumor tissue ex vivo to estimate drug response, in pediatric and adult subjects. CNS tumors display remarkable heterogeneity and unfortunately there are no reliable precision oncology platforms that can identify the most effective therapy for each patient. Recent work has demonstrated the success of functional precision oncology platforms using patient-derived explant (PDE) at predicting drug response in various cancers. Since PDEs maintain important aspects of tumor heterogeneity they may prove effective as functional models for CNS tumors. The purpose of this study is to explore the feasibility of using a novel PDE platform to generate drug sensitivity scores from patients with central nervous system tumors in Pediatric and adult subjects having low- or high-grade CNS tumors resected. The secondary objective is to estimate the proportion of successfully scaled PDEs generated per given tumor size.

CONDITIONS

Official Title

Brain Slice Explants to Predict Drug Response in Brain Tumors

Who Can Participate

All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Written informed consent obtained or parental/surrogate consent for pediatric subjects
  • Diagnosed with a tumor in the central nervous system planned for surgical removal
  • Willing and able to comply with study procedures as judged by the investigator
Not Eligible

You will not qualify if you...

  • Having any serious medical or psychiatric disorder interfering with informed consent
  • Being currently incarcerated

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

UNC Lineberger Comprehensive Cancer Center

Chapel Hill, North Carolina, United States, 27516

Actively Recruiting

Loading map...

Research Team

D

Devin McCarthy

CONTACT

L

Luz Cuaboy

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here